SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Link Pharma Chem - Quaterly Results

14 Aug 2023 Evaluate
The sales slipped to Rs. 78.76 millions, down -32.30% for the June 2023 quarter as against Rs. 116.34 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -8.24 millions as compared to Net Loss of Rs. -2.92 millions of corresponding quarter ended June 2022Operating profit Margin for the quarter ended June 2023 slipped to -6.56% as compared to 0.40% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 78.76 116.34 -32.30 78.76 116.34 -32.30 387.58 535.61 -27.64
Other Income 3.07 -8.11 -137.85 3.07 -8.11 -137.85 -1.47 4.64 -131.68
PBIDT -6.56 0.40 -1740.00 -6.56 0.40 -1740.00 25.69 40.01 -35.79
Interest 2.29 1.68 36.31 2.29 1.68 36.31 7.61 4.51 68.74
PBDT -8.85 -1.28 591.41 -8.85 -1.28 591.41 18.08 35.50 -49.07
Depreciation 2.58 2.26 14.16 2.58 2.26 14.16 9.23 9.28 -0.54
PBT -11.43 -3.54 222.88 -11.43 -3.54 222.88 8.85 26.22 -66.25
TAX -3.19 -0.62 414.52 -3.19 -0.62 414.52 2.32 7.40 -68.65
Deferred Tax -3.19 -2.25 41.78 -3.19 -2.25 41.78 -1.83 0.73 -350.68
PAT -8.24 -2.92 182.19 -8.24 -2.92 182.19 6.53 18.82 -65.30
Equity 44.41 44.41 0.00 44.41 44.41 0.00 44.41 44.41 0.00
PBIDTM(%) -8.33 0.34 -2522.66 -8.33 0.34 -2522.66 6.63 7.47 -11.27

Link Pharma Chem Share Price

29.49 1.49 (5.32%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×